[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 249
Citations 0
Invited Commentary
September 2013

Breast Cancer Stem Cells—Ready for Their Close-up?

Author Affiliations
  • 1Division of Surgical Oncology, Department of Surgery, University of Washington School of Medicine, Seattle
JAMA Surg. 2013;148(9):878. doi:10.1001/jamasurg.2013.3070

A growing body of evidence suggests that malignant stem cells have a role in the growth, spread, and clinical outcomes of breast cancers. In “Correlation of Breast Cancer Axillary Lymph Node Metastases With Stem Cell Mutations,” Donovan et al1 have built on prior notable works devoted to understanding the behavior of breast cancers. This group of authors previously demonstrated that breast cancer stem cells are distinctively different compared with benign and progenitor stem cells found in normal breast tissue, especially with regard to mutations in genes critical for maintaining normal cellular metabolism and proliferation.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×